发明名称 CD45 INHIBITORS
摘要 Substituted phenantheren-9, 10-diones in accord with structural diagram (I), compositions thereof and methods for the use thereof, for the treatment of T cell mediated conditions such as autoimmune diseases and organ graft rejection. In compounds of the invention, R<1> at each occurrence is independently selected from hydrogen, halogen, NH-tosyl, N-di-tosyl, NH2, NO2, NH-CO-R<2>, CO-NH-R<2>, Ar, (CH2)nCH(COOH)R<3> COR<3> and NHCOCH2CH(COOH)NHR<4>, where R<2>, R<3> and R<4> are a selected from a variety of substituted or unsubstituted alkyl and aryl groups and oligopeptides.
申请公布号 WO0146125(A2) 申请公布日期 2001.06.28
申请号 WO2000GB04854 申请日期 2000.12.18
申请人 ASTRAZENECA AB;ASTRAZENECA UK LIMITED;CHAPDELAINE, MARC, JEROME;KNAPPENBERGER, KATHERINE;STEELMAN, GARY;SUCHARD, SUZANNE;SYGOWSKI, LINDA;URBANEK, REBECCA;VEALE, CHRIS, ALLAN 发明人 CHAPDELAINE, MARC, JEROME;KNAPPENBERGER, KATHERINE;STEELMAN, GARY;SUCHARD, SUZANNE;SYGOWSKI, LINDA;URBANEK, REBECCA;VEALE, CHRIS, ALLAN
分类号 C07D317/54;A61K31/122;A61K31/136;A61K31/166;A61K31/167;A61K31/18;A61K31/192;A61K31/198;A61K31/223;A61K31/225;A61K31/27;A61K31/343;A61K31/36;A61K31/381;A61K38/00;A61P37/02;C07C50/16;C07C50/20;C07C50/24;C07C50/34;C07C50/38;C07C205/46;C07C225/32;C07C233/33;C07C233/76;C07C235/16;C07C235/38;C07C235/74;C07C235/84;C07C237/22;C07C311/21;C07C311/48;C07C311/51;C07D307/80;C07D317/26;C07D333/22;C07K5/06;C07K5/072;C07K5/113;C07K7/06;(IPC1-7):C07C237/00 主分类号 C07D317/54
代理机构 代理人
主权项
地址